Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ardelyx Inc ARDX

Healthcare Biotechnology
Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. It has two commercial products IBSRELA (tenapanor) and XPHOZAH. Its product pipeline includes RDX013 Program and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control... see more

Recent & Breaking News (NDAQ:ARDX)

INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile September 3, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OTLY, AHCO and ARDX

Accesswire September 3, 2021

Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial

PR Newswire September 3, 2021

CLASS ACTION UPDATE for PLL, OTLY and ARDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 2, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadline - ARDX

Newsfile September 2, 2021

SHAREHOLDER ALERT: COIN ARDX ATVI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 2, 2021

ARDX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Ardelyx, Inc.

Newsfile September 1, 2021

ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc. Limited Shareholders

Newsfile September 1, 2021

Rosen, Globally Recognized Investor Counsel, Encourages Ardelyx, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - ARDX

Newsfile September 1, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ardelyx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 28, 2021 - ARDX

Newsfile September 1, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ARDX, YALA and HYRE

Accesswire September 1, 2021

CLASS ACTION UPDATE for DIDI, ARDX and SESN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 1, 2021

SHAREHOLDER ALERT: OTLY ARDX HYRE: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 1, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ardelyx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 28, 2021 - ARDX

Newsfile August 31, 2021

ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc. Limited Shareholders

Newsfile August 30, 2021

ROSEN, A TOP RANKED LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action - ARDX

Business Wire August 30, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of DKNG, ARDX and ANVS

Accesswire August 30, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ardelyx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 28, 2021 - ARDX

Newsfile August 30, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ARDX, ITRM and VIEW

Accesswire August 30, 2021

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Ardelyx Inc.

PR Newswire August 29, 2021